Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (8) , 1221-1227
- https://doi.org/10.1016/0006-2952(78)90455-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- The value of adriamycin in overcoming resistance to methotrexate in tissue culturePublished by Elsevier ,1976
- Affinity of adriamycin to phospholipids a possible explanation for cardiac mitochondrial lesionsBiochemical and Biophysical Research Communications, 1976
- Cellular pharmacodynamics of several anthracycline antibioticsJournal of Medicinal Chemistry, 1976
- Specificity of sugar-phospholipid interactionsArchives of Biochemistry and Biophysics, 1973
- Active outward transport of daunomycin in resistant ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973
- Inhibition of parallel flux and augmentation of counter flux shown by transport models not involving a mobile carrierJournal of Theoretical Biology, 1966
- On physico-chemical interactions between daunomycin and nucleic acidsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1965
- Phospholipid-Sugar Complexes in Relation to Cell Membrane Monosaccharide TransportScience, 1964
- Reactive Sites and Biological TransportPublished by Elsevier ,1961